Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART

This publication has 16 references indexed in Scilit:

• Breastfeeding Plus Infant Zidovudine Prophylaxis for 6 Months vs Formula Feeding Plus Infant Zidovudine for 1 Month to Reduce Mother-to-Child HIV Transmission in Botswana
  JAMA, 2006
• Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana
  AIDS, 2006
• Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission
  Proceedings of the National Academy of Sciences, 2006
• Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission
  AIDS, 2006
• Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns
  AIDS, 2005
• Sensitive Drug‐Resistance Assays Reveal Long‐Term Persistence of HIV‐1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single‐Dose NVP: HIVNET 012
  The Journal of Infectious Diseases, 2005
• Emergence of Drug‐Resistant HIV‐1 after Intrapartum Administration of Single‐Dose Nevirapine Is Substantially Underestimated
  The Journal of Infectious Diseases, 2005
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy
  New England Journal of Medicine, 2004
• Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand
  New England Journal of Medicine, 2004
• Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
  AIDS, 2001